Given the synergistic roles of increased complement activity and kinin/kallikrein system activation in cerebral edema, these findings suggest that gC1qR targeting should be domain-specific to mediate these distinct proinflammatory pathways implicated in AIS. The gene discussed is C1QBP; the disease is brain edema.